On the other hand, the dysregulation of the Akt signaling pathway, which operates downstream of the insulin signaling, has been implicated in altered glucose metabolism, which is a key aspect of obesity-related metabolic dysfunction (112, 113). The gene discussed is AKT1; the disease is obesity disorder.